Skip to main content

Table 3 Use of medication after vaccination against COVID-19 according to the severity of adverse events among health professionals, Togo, 2021

From: Prevalence of severe adverse events among health professionals after receiving the first dose of the ChAdOx1 nCoV-19 coronavirus vaccine (Covishield) in Togo, March 2021

 

Adverse events after COVID-19 vaccination

P

 

None

Moderate

Severe

Overall

 

(n = 442)

(n = 807)

(n = 390)

(n = 1,639)

Analgesics, n (%)

23 (5.2)

315 (39.0)

243 (62.3)

581 (35.4)

<0.001*

Antipyretics, n (%)

15 (3.4)

207 (25.7)

181 (46.4)

403 (24.6)

<0.001*

NSAIDs$, n (%)

10 (2.3)

82 (10.2)

65 (16.7)

157 (9.6)

<0.001*

Antihistamines, n (%)

1 (0.2)

23 (2.9)

43 (11.0)

67 (4.1)

<0.001**

Vitamin C, n (%)

1 (0.2)

19 (2.4)

17 (4.4)

37 (2.3)

<0.001**

Herbal medicines/infusions, n (%)

0 (0.0)

12 (1.5)

14 (3.6)

26 (1.6)

<0.001**

  1. $NSAIDs: non-steroidal anti-inflammatory drugs
  2. *Chi-squared test; **Fisher test